korrents
Elliot Hershberg

Elliot Hershberg

@elliot-hershberg · 21 positions · On ppll ↗

Genomics researcher and investor; writes The Century of Biology on where biotechnology is actually going.

Elliot Hershberg did not write this page.

We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.

  1. AI and science

    It's becoming more clear each day that the next chapter of this story is AI.

    ↗CSHL: AI in Biologycenturyofbio.com 1st of 3 in this piece

  2. AI and scienceAI agents

    We are very early in the development of agentic systems in biology.

    ↗CSHL: AI in Biologycenturyofbio.com 2nd of 3 in this piece

  3. AI and science

    In other words, computer science has already revolutionized biological research.

    ↗CSHL: AI in Biologycenturyofbio.com 3rd of 3 in this piece

  4. 2 months earlier
  5. Biotech R&D efficiency and pharma R&D efficiency are not the same thing.

    ↗AI Versus Eroom's Lawcenturyofbio.com 1st of 3 in this piece

  6. AI and science

    New technologies can and do make an impact on R&D productivity.

    ↗AI Versus Eroom's Lawcenturyofbio.com 2nd of 3 in this piece

  7. startupsPsychotherapyinnovation

    Relying on pharma as top-down tastemakers can stifle the emergence of new therapeutic ideas from startups.

    ↗AI Versus Eroom's Lawcenturyofbio.com 3rd of 3 in this piece

  8. 3 months earlier
  9. Cancer is a disease of information. Loss of genomic information threatens to destroy the self.

    ↗Going Founder Mode On Cancercenturyofbio.com 1st of 3 in this piece

  10. ChinaAmerica

    In recent years, China has adopted a dramatically different posture towards testing experimental medicines that now threatens the future competitiveness of the American biotech sector.

    ↗Going Founder Mode On Cancercenturyofbio.com 2nd of 3 in this piece

  11. AI and scienceinnovation

    Drug discovery has gotten less efficient over time despite extraordinary technological progress.

    ↗Going Founder Mode On Cancercenturyofbio.com 3rd of 3 in this piece

  12. 8 weeks earlier
  13. infrastructure

    But I don't think that means there can't be massive, objectively investable infrastructure businesses that create a lot of value for the industry.

    ↗On AI Infrastructure in Biologycenturyofbio.com 1st of 3 in this piece

  14. the cloud

    In this type of transition, it's incredibly hard for one platform company to offer every solution needed to build the next wave of applications.

    ↗On AI Infrastructure in Biologycenturyofbio.com 2nd of 3 in this piece

  15. AI and scienceprotein structure prediction

    Compared to experiments, AI models have a few advantages: They can average out background experimental noise, incorporate priors from massive data sets like the PDB, and interpolate between nearby data points.

    ↗On AI Infrastructure in Biologycenturyofbio.com 3rd of 3 in this piece

  16. 5 months earlier
  17. physics

    Molecular biology is not like physics. The complexity-and nonlinearity-of living systems has required a brute force approach to knowledge creation and dissemination.

    ↗What Are Virtual Cells?centuryofbio.com 1st of 3 in this piece

  18. protein structure prediction

    After decades of research-including lots of attempted math and software 1.0-the problem of 3D protein structure prediction was effectively solved by deep learning.

    ↗What Are Virtual Cells?centuryofbio.com 2nd of 3 in this piece

  19. AI and science

    For human cells, with billions of DNA base pairs and tens of thousands of genes, the timeline for mechanistic whole-cell models is much less certain.

    ↗What Are Virtual Cells?centuryofbio.com 3rd of 3 in this piece

  20. 3 months earlier
  21. ChinaAmerica

    China has become a serious competitive threat in biotech, demonstrating the capacity to rapidly develop new drugs that can rival-or surpass-those being produced in American labs.

    ↗On Modality Commoditizationcenturyofbio.com 1st of 3 in this piece

  22. AI and scienceinnovation

    no discovery technology is immune from the inescapable pull towards commoditization-like virtually every other technology.

    ↗On Modality Commoditizationcenturyofbio.com 2nd of 3 in this piece

  23. innovation

    Over time, revolutionary ideas become universal building blocks for the next wave of innovation.

    ↗On Modality Commoditizationcenturyofbio.com 3rd of 3 in this piece

  24. 4 weeks earlier
  25. innovation

    What we haven't seen is the same type of frantic hunt for every nugget of value that could be commercialized as a result of this enormous secular trend.

    ↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 1st of 3 in this piece

  26. innovation

    The set of diseases for which we have a molecular explanation-which resembles the equivalent of the Craigslist homepage for this analogy-has grown far faster than the corresponding set of new drugs to treat them.

    ↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 2nd of 3 in this piece

  27. AI and science

    I think this partially explains some of the discontent in the scientific community about the Human Genome Project. After billions of dollars that could have been spent in other places, the result is less transformative than initially advertised.

    ↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 3rd of 3 in this piece